Literature DB >> 30950501

Discovery of False Elite Controllers: HIV Antibody-Positive RNA-Negative Blood Donors Found To Be on Antiretroviral Therapy.

Wendy Sykes1, Karin Van den Berg2, Genevieve Jacobs3, Adam Jauregui4, Nareg Roubinian5, Lubbe Wiesner6, Gary Maartens6, Ronel Swanevelder3, Brian Custer4, Michael Busch4, Ute Jentsch3, Edward L Murphy4,5, Marion Vermeulen3.   

Abstract

BACKGROUND: An increase in potential HIV elite controllers (EC) and anecdotal reports of antiretroviral therapy (ART) use among South African blood donors led us to verify EC status.
METHODS: Stored plasma samples from potential EC were tested for ART drugs. Demographic and temporal associations were examined using multivariable logistic regression.
RESULTS: Of 226 potential EC, 150 (66.4%) had detectable ART with increasing prevalence by year (OR = 7.57 for 2016 vs 2010, 95% confidence interval, 1.96-32.17). DISCUSSION: False presumptive EC status due to undisclosed ART represents a growing proportion of potential EC donors in South Africa coincident with the country's ART rollout.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Keywords:  HIV; South Africa; antiretroviral therapy; blood donors; disclosure; elite controller

Mesh:

Substances:

Year:  2019        PMID: 30950501      PMCID: PMC6639597          DOI: 10.1093/infdis/jiz145

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

Authors:  Jessica M Fogel; Lei Wang; Teresa L Parsons; San-San Ou; Estelle Piwowar-Manning; Ying Chen; Victor O Mudhune; Mina C Hosseinipour; Johnstone Kumwenda; James G Hakim; Suwat Chariyalertsak; Ravindre Panchia; Ian Sanne; Nagalingeswaran Kumarasamy; Beatriz Grinsztejn; Joseph Makhema; Jose Pilotto; Breno R Santos; Kenneth H Mayer; Marybeth McCauley; Theresa Gamble; Namandjé N Bumpus; Craig W Hendrix; Myron S Cohen; Susan H Eshleman
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

2.  Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.

Authors:  Piotr Grabarczyk; Marco Koppelman; Fiona Boland; Silvia Sauleda; Cécile Fabra; Giuseppe Cambie; Aneta Kopacz; Karen O'Riordan; Harry van Drimmelen; Joan O'Riordan; Nico Lelie
Journal:  Transfusion       Date:  2015-06-23       Impact factor: 3.157

Review 3.  Epidemiology and clinical characteristics of elite controllers.

Authors:  Jason F Okulicz; Olivier Lambotte
Journal:  Curr Opin HIV AIDS       Date:  2011-05       Impact factor: 4.283

4.  Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.

Authors:  Marion Vermeulen; Charl Coleman; Josephine Mitchel; Ravi Reddy; Harry van Drimmelen; Tracy Fickett; Michael Busch; Nico Lelie
Journal:  Transfusion       Date:  2013-02-27       Impact factor: 3.157

5.  Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.

Authors:  Piotr Grabarczyk; Harry van Drimmelen; Aneta Kopacz; Jolanta Gdowska; Grzegorz Liszewski; Dariusz Piotrowski; Joanna Górska; Jolanta Kuśmierczyk; Daniel Candotti; Magdalena Lętowska; Nico Lelie; Ewa Brojer
Journal:  Transfusion       Date:  2013-04-17       Impact factor: 3.157

6.  Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology.

Authors:  Mark S de Souza; Suteeraporn Pinyakorn; Siriwat Akapirat; Supanit Pattanachaiwit; James L K Fletcher; Nitiya Chomchey; Eugene D Kroon; Sasiwimol Ubolyam; Nelson L Michael; Merlin L Robb; Praphan Phanuphak; Jerome H Kim; Nittaya Phanuphak; Jintanat Ananworanich
Journal:  Clin Infect Dis       Date:  2016-06-17       Impact factor: 9.079

7.  Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Authors:  Marion Vermeulen; Nico Lelie; Wendy Sykes; Robert Crookes; Johanna Swanevelder; Lilian Gaggia; Martin Le Roux; Eben Kuun; Sam Gulube; Ravi Reddy
Journal:  Transfusion       Date:  2009-02-27       Impact factor: 3.157

8.  The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion.

Authors:  Deborah Donnell; Eric Ramos; Connie Celum; Jared Baeten; Joan Dragavon; Jordan Tappero; Jairam R Lingappa; Allan Ronald; Kenneth Fife; Robert W Coombs
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

9.  The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?

Authors:  Sulggi A Lee; Steven G Deeks
Journal:  EBioMedicine       Date:  2016-08-05       Impact factor: 8.143

10.  Defective proviruses rapidly accumulate during acute HIV-1 infection.

Authors:  Katherine M Bruner; Alexandra J Murray; Ross A Pollack; Mary G Soliman; Sarah B Laskey; Adam A Capoferri; Jun Lai; Matthew C Strain; Steven M Lada; Rebecca Hoh; Ya-Chi Ho; Douglas D Richman; Steven G Deeks; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Med       Date:  2016-08-08       Impact factor: 53.440

View more
  11 in total

1.  HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern.

Authors:  Brian Custer; Claire Quiner; Richard Haaland; Amy Martin; Mars Stone; Rita Reik; Whitney R Steele; Debra Kessler; Phillip C Williamson; Steven A Anderson; Alan E Williams; Henry F Raymond; Willi McFarland; William T Robinson; Sara Glick; Kwa Sey; C David Melton; Simone A Glynn; Susan L Stramer; Michael P Busch
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113

Review 2.  Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.

Authors:  Rahaman Ademolu Ahmed; Khalid Olajide Adekoya; Chika Kingsley Onwuamah; Bolanle Olufunmilayo Oboh; Smita Swaminathan Iyer; Ayomide Samuel Oluwatosin; Rosemary Ajuma Audu; Oliver Chukwujekwu Ezechi
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

3.  The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

Authors:  Cassandra D Josephson; Simone Glynn; Sunitha Mathew; Rebecca Birch; Sonia Bakkour; Lisa Baumann Kreuziger; Michael P Busch; Kathleen Chapman; Carla Dinardo; Jeanne Hendrickson; Eldad A Hod; Shannon Kelly; Naomi Luban; Alan Mast; Philip Norris; Brian Custer; Ester Sabino; Bruce Sachais; Bryan R Spencer; Mars Stone; Steve Kleinman
Journal:  Transfusion       Date:  2022-04-19       Impact factor: 3.337

4.  HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods.

Authors:  Marion Vermeulen; Dhuly Chowdhury; Ronel Swanevelder; Eduard Grebe; Donald Brambilla; Ute Jentsch; Michael Busch; Gert Van Zyl; Edward L Murphy
Journal:  Vox Sang       Date:  2020-08-06       Impact factor: 2.144

Review 5.  Pharmacology of HIV Cure: Site of Action.

Authors:  Aaron S Devanathan; Mackenzie L Cottrell
Journal:  Clin Pharmacol Ther       Date:  2021-03-05       Impact factor: 6.875

6.  Undisclosed HIV status and antiretroviral therapy use among South African blood donors.

Authors:  Karin van den Berg; Marion Vermeulen; Vernon J Louw; Edward L Murphy; Gary Maartens
Journal:  Transfusion       Date:  2021-07-05       Impact factor: 3.337

Review 7.  Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.

Authors:  Marion C Lanteri; Felicia Santa-Maria; Andrew Laughhunn; Yvette A Girard; Marcus Picard-Maureau; Jean-Marc Payrat; Johannes Irsch; Adonis Stassinopoulos; Peter Bringmann
Journal:  Transfusion       Date:  2020-04-24       Impact factor: 3.157

8.  Comment to: Test seeking: are health care professionals referring people to the blood centers for infectious markers testing?

Authors:  José Eduardo Levi
Journal:  Hematol Transfus Cell Ther       Date:  2019-07-26

9.  Does antiretroviral therapy use affect the accuracy of HIV rapid diagnostic assays? Experience from a demographic health and surveillance site in rural South Africa.

Authors:  Mark J Siedner; Kathy Baisley; Olivier Koole; Innocentia Mpofana; Gregory Ording-Jespersen; Philippa Matthews; Kobus Herbst; Theresa Smit; Deenan Pillay
Journal:  Diagn Microbiol Infect Dis       Date:  2020-03-02       Impact factor: 2.803

10.  Undisclosed exposure to antiretrovirals prior to treatment initiation: An exploratory analysis.

Authors:  Lufuno G Mavhandu-Ramarumo; Lisa A M Tambe; Nontokozo D Matume; David Katerere; Pascal O Bessong
Journal:  South Afr J HIV Med       Date:  2021-04-08       Impact factor: 2.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.